|
STARD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.069170E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.620300E-03 |
| Normal-vs-Stage2 |
7.372400E-02 |
| Normal-vs-Stage3 |
9.697200E-01 |
| Normal-vs-Stage4 |
4.093200E-01 |
| Stage1-vs-Stage2 |
7.885800E-01 |
| Stage1-vs-Stage3 |
1.270310E-02 |
| Stage1-vs-Stage4 |
1.103910E-03 |
| Stage2-vs-Stage3 |
5.045800E-02 |
| Stage2-vs-Stage4 |
2.166100E-02 |
| Stage3-vs-Stage4 |
4.343400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.036000E-02 |
| Normal-vs-AfricanAmerican |
2.336800E-01 |
| Normal-vs-Asian |
3.238600E-01 |
| Caucasian-vs-AfricanAmerican |
9.155000E-03 |
| Caucasian-vs-Asian |
4.960200E-01 |
| AfricanAmerican-vs-Asian |
1.109200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.029170E-01 |
| Normal-vs-Female |
2.346800E-01 |
| Male-vs-Female |
7.256200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.185200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.801800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.159000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.603200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.353900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.460830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.058780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.673400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.082000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.786600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.756400E-02 |
| Normal-vs-Grade 2 |
6.359000E-03 |
| Normal-vs-Grade 3 |
5.388600E-01 |
| Normal-vs-Grade 4 |
2.659600E-01 |
| Grade 1-vs-Grade 2 |
8.494000E-01 |
| Grade 1-vs-Grade 3 |
2.485600E-01 |
| Grade 1-vs-Grade 4 |
4.799900E-02 |
| Grade 2-vs-Grade 3 |
1.538260E-02 |
| Grade 2-vs-Grade 4 |
4.158600E-04 |
| Grade 3-vs-Grade 4 |
9.172300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.950900E-04 |
| Normal-vs-ccB subtype |
6.047600E-01 |
| ccA subtype-vs-ccB subtype |
8.773400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.330100E-02 |
| Normal-vs-N1 |
1.870190E-01 |
| N0-vs-N1 |
9.267600E-02 |
|
|
